Home/ Science Resources/ Publications

Research and Publications

  • 64

    Research Trials

  • 29

    Peer-reviewed publications

  • 17

    Clinical Conditions

Showing 73 publications

2026

  1. Abstract28 Oct 2026 · ERS Congress 2026

    ERS 2026: Continuous cough monitoring surrounding COPD exacerbations: interim findings from a prospective multi-center study

    Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

    Topics: COPDExacerbations

  2. Abstract28 Oct 2026 · ERS Congress 2026

    ERS 2026: Unobtrusive continuous recording of cough in refractory/unexplained chronic cough: daily variability and relationship to patient-reported outcomes

    A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

    Topics: Chronic coughTrial endpoints & variability

  3. Peer-reviewed1 Oct 2026 · PLOS Global Public Health

    Evaluating smartphone-based cough frequency monitoring for tuberculosis screening and triage in Uganda: A mixed-methods evaluation

    Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.

    Topics: TuberculosisScreening & diagnosis

  4. Peer-reviewed15 Sep 2026 · Scientific Reports

    Cough hypersensitivity risk increases during heatwaves and can be reduced by inhalation of alkaline aerosols of endogenous ions

    Mechanistic and clinical study linking heatwave-level air dryness to cough hypersensitivity, with a placebo-controlled pilot trial showing reduced cough bouts after alkaline divalent salt aerosols, measured with Hyfe continuous cough monitoring.

    Topics: Chronic coughTreatment response

  5. Abstract20 Aug 2026 · ERS Cough Conference 2026

    ERS Cough Conference 2026: Cough-predominant asthma in difficult-to-treat (DTT) and severe disease: a study using patient-reported outcomes and objective cough monitoring

    Pilot study in cough-predominant difficult-to-treat and severe asthma using eight weeks of Hyfe continuous monitoring, showing highly variable cough not captured by asthma questionnaires.

    Topics: AsthmaTrial endpoints & variabilityExacerbations

  6. Peer-reviewed27 Jun 2026 · Lung

    Validation Approaches for Cough Monitoring Tools: A Scoping Review

    Scoping review of 50 validation studies of ambulatory cough monitoring systems, showing wide variation in reference standards, cough definitions and outcome metrics, and calling for standardized validation protocols.

    Topics: Validation

  7. Abstract24 Jun 2026 · World Bronchiectasis Conference 2026

    World Bronchiectasis Conference 2026: Validation of a Privacy-Preserving Cough Monitoring Smartwatch Against Human-Annotated Ground Truth in Adults with Chronic

    Real-world validation of Hyfe’s fully on-device cough monitoring smartwatch against expert human annotation in 31 adults, showing high agreement for hourly and daily cough counts.

    Topics: Chronic coughValidation

  8. Peer-reviewed22 Jun 2026 · ERJ Open Research

    Measuring the effect of azithromycin in chronic respiratory disease using continuous cough monitoring: an open-label exploratory trial

    First study to assess the antitussive effect of a drug using continuous cough monitoring, tracking patients on a Hyfe-enabled smartwatch for five weeks around the start of azithromycin.

    Topics: Chronic coughCOPDIPFAsthmaTreatment response

  9. Abstract18 Jun 2026 · ATS 2026

    ATS 2026: Continuous Cough Monitoring for Early Detection of COPD Exacerbations Using Hyfe (COPD-HYFE): Interim Results From a Prospective Multi-center Cohort Study

    Interim results from the first continuous, 24/7 characterization of cough in COPD, showing excellent adherence to wearable monitoring and early signs of cough changes before exacerbations.

    Topics: COPDExacerbations

  10. Abstract18 Jun 2026 · ATS 2026

    ATS 2026: Daily Cough Count Variability and Correlation With PROs in Chronic Cough: Informing Antitussive Trial Endpoints

    Continuous monitoring in stable refractory/unexplained chronic cough shows high day-to-day variability and poor agreement between daily VAS scores and objective cough counts, with direct implications for trial enrollment and endpoints.

    Topics: Chronic coughTrial endpoints & variability

  11. Peer-reviewed26 May 2026 · Scientific Reports

    External validation of cough-based algorithms for pulmonary tuberculosis screening from the CODA TB DREAM challenge using cough data from Peru

    External validation of the CODA TB DREAM Challenge cough-only models in an independent Peruvian cohort recorded with the Hyfe Research app, showing reduced performance outside the original training populations.

    Topics: TuberculosisScreening & diagnosis

2025

  1. Peer-reviewed29 Dec 2025 · ERJ Open Research

    Telehealth group behavioural cough-suppression therapy for refractory chronic cough using a rolling enrolment model

    Pilot cohort study of behavioural cough suppression therapy delivered to small telehealth groups with rolling enrolment, with exploratory objective cough monitoring using Hyfe’s CoughPro app.

    Topics: Chronic coughDigital TherapeuticsTreatment response

  2. Abstract4 Dec 2025 · American Cough Conference 2025

    A Prospective Decentralized Pilot Study Assessing a Digital Therapeutic Feature Inside CoughPro: For Adults with RCC/UCC

    Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.

    Topics: Chronic coughDigital Therapeutics

  3. Peer-reviewed30 Nov 2025 · Journal of Thoracic Disease

    The value of continuous cough monitoring: a narrative review

    This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.

    Topics: Trial endpoints & variabilityValidation

  4. Abstract18 Nov 2025 · ERS Congress 2025

    ERS 2025: Azithromycin and continuous cough monitoring: an open-label trial

    Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.

    Topics: Chronic coughCOPDIPFTreatment response

  5. Abstract18 Nov 2025 · ERS Congress 2025

    ERS 2025: Azithromycin and Oesophageal Motility in Chronic Respiratory Disease: A Feasibility Trial

    Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.

    Topics: Chronic coughCOPDIPFTreatment response

  6. Abstract18 Nov 2025 · ERS Congress 2025

    ERS 2025: Continuous cough monitoring to evaluate tolerance to inhaled antibiotic treatment in patients with chronic bronchial infection

    Independent ERS 2025 pilot uses the Hyfe Cough Monitoring System to track inhaled antibiotic tolerance in bronchiectasis, flagging adverse responses early.

    Topics: BronchiectasisTreatment response

  7. Abstract18 Nov 2025 · ERS Congress 2025

    ERS 2025: Objective Assessment of Adherence in Continuous Cough Monitoring: Wear Detection on the Hyfe CoughMonitor Smartwatch

    This ERS 2025 abstract from Hyfe's R&D team validates the wear-detection algorithm built into the Hyfe CoughMonitor smartwatch against participant-reported wear status across 418 person-hours of data in ten participants.

    Topics: Validation

  8. Abstract18 Nov 2025 · ERS Congress 2025

    ERS 2025: Optimizing Cough Frequency Assessment: A 7-Day Monitoring Standard

    Hyfe ERS 2025 abstract presents evidence for a 7-day cough monitoring standard, replacing 24-hour windows long used in respiratory clinical research.

    Topics: Chronic coughTrial endpoints & variability

  9. Research memo11 Nov 2025 · EMJ Respiratory

    Counting Coughs: ERS 2025 Highlights on Objective Cough Monitoring

    Authored by Hyfe's R&D team, this review synthesizes work presented at the European Respiratory Society Congress 2025 and argues that objective cough monitoring has crossed a practical threshold, moving from experimental technique to deployable clinical endpoint.

    Topics: ValidationTrial endpoints & variability

  10. Abstract21 Oct 2025 · CHEST 2025

    CHEST 2025: Digital therapeutic for refractory and unexplained chronic cough: a proof of concept study

    Proof-of-concept study of behavioural cough suppression therapy delivered through the CoughPro app, showing a 42% drop in objectively measured cough rate and meaningful quality of life gains in 8 of 10 patients.

    Topics: Chronic coughDigital TherapeuticsTreatment response

  11. Peer-reviewed16 Sep 2025 · Open Forum Infectious Diseases

    Accelerating Cough-Based Algorithms for Pulmonary Tuberculosis Screening: Results From the CODA TB DREAM Challenge

    Topics: TuberculosisScreening & diagnosis

  12. Peer-reviewed4 Sep 2025 · American Journal of Speech-Language Pathology

    Internet-Based Behavioral Cough Suppression Therapy for Refractory Chronic Cough: A Randomized Controlled Trial

    This randomized controlled trial tested whether behavioral cough suppression therapy, a treatment that normally requires in-person visits with a specialized speech-language pathologist, could be delivered entirely online.

    Topics: Chronic coughDigital TherapeuticsTreatment response

  13. Peer-reviewed30 Jul 2025 · Therapeutic Advances in Respiratory Disease

    Azithromycin and oesophageal motility in chronic respiratory disease: a feasibility study

    A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.

    Topics: Chronic coughCOPDIPFTreatment response

  14. Abstract14 May 2025 · ATS 2025

    ATS 2025: A Proof of Concept Therapeutic Solution for Chronic Cough: Personalized Monitoring and Targeted Suppression

    The world’s first DTx for Refractory/Unexplained Chronic Cough (RCC/UCC). What it is? Digitally delivered behavioral cough suppression therapy (BCST), designed for high engagement to promote strong adherence. It includes continuous, passive cough monitoring and biofeedback loop enabling tailored personalization.

    Topics: Chronic coughDigital Therapeutics

  15. Abstract14 May 2025 · ATS 2025

    ATS 2025: ARINA-1 Improves Quality of Life in a Pilot Study of Chronic Bronchitis

    This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.

    Topics: COPDTreatment response

  16. Abstract14 May 2025 · ATS 2025

    ATS 2025: Defining a 7-day Standard for Cough Monitoring: Data-driven Insights on Optimal Duration

    A 7-day monitoring duration provides a robust, standardized timeframe for assessing cough frequency in clinical studies, offering a significant improvement over the traditional 24-hour period. This duration captures inter- and intra-individual cough variability.

    Topics: Chronic coughTrial endpoints & variability

  17. Abstract14 May 2025 · ATS 2025

    ATS 2025: Evaluating Cough Bouts as a Metric for Cough Severity

    Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.

    Topics: Chronic coughTrial endpoints & variability

  18. Peer-reviewed6 Jan 2025 · Scientific Reports

    Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study

    This analysis of cough events demonstrated that the Hyfe CoughMonitor smartwatch, compared to a human listener, accurately detects coughs, with high sensitivity and a low false positive rate. Future studies should focus on its potential role in the management of patients with cough in clinical practice.

    Topics: Validation

2024

  1. Peer-reviewed18 Oct 2024 · Scientific Data

    A dataset of Solicited Cough Sound for Tuberculosis Triage Testing

    The article presents a dataset of 733,756 cough sounds from 2,143 patients across 7 countries, accompanied by accurate demographic, clinical, and microbiological diagnostic annotations. It was collected using an early version of Hyfe’s research application, specifically designed to capture cough audio.

    Topics: TuberculosisScreening & diagnosis

  2. Peer-reviewed8 Oct 2024 · ERJ Open Research

    Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency

    This is an exploratory, single-blind, nasal saline-controlled study involving 12 patients with refractory chronic cough, designed to examine the cough suppression efficacy of alkaline salts, monitored objectively with the previous version of the Hyfe CoughMonitor Suite.

    Topics: Chronic coughTreatment response

  3. Abstract1 Oct 2024 · ERS Congress 2024

    ERS 2024: Differentiating Cough Origins in Non-Contact AI Monitoring: Analyzing 'Non-User Coughs' with the Hyfe CoughMonitor Smartwatch

    This pilot work clarifies a methodology for quantifying this phenomenon and provides preliminary evidence that non-user coughs have a negligible effect on the cough estimates of the Hyfe Cough Monitor Watch in real-world settings.

    Topics: Validation

  4. Abstract1 Oct 2024 · ERS Congress 2024

    ERS 2024: Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency.

    A single-blinded study in 12 chronic cough patients evaluated the cough-suppression efficacy of nasally delivered SC001 (pH 8 or 9) versus saline. Using Hyfe CoughMonitor, patients were monitored over three weeks. Results suggest alkaline (pH 9) SC001 aerosol shows promise for refractory chronic cough treatment.

    Topics: Chronic coughTreatment response

  5. Abstract1 Oct 2024 · ERS Congress 2024

    ERS 2024: Is there a relationship between real-time continuous cough monitoring and subjective cough assessment?

    A 30-day study of 12 chronic cough patients found no correlation between daily cough counts (median: 93/day) measured by the Hyfe CoughMonitor and symptom severity assessed via the Cough VAS. Further research is needed to identify better endpoints for evaluating chronic cough treatments.

    Topics: Chronic coughTrial endpoints & variability

  6. Abstract1 Oct 2024 · ERS Congress 2024

    ERS 2024: Longitudinal Cough Frequency Monitoring in Subjects with Persistent Cough: Daily Variability and Predictability Over 30 Days

    Coughing frequencies vary significantly between and within individuals, for those with a cough frequency of >5 coughs/h. One 24-hour measurement of cough does not reliably reflect long-term trends in up to half of those with persistent cough. This work provides methodological direction for subsequent definitive studies

    Topics: Chronic coughTrial endpoints & variability

  7. Abstract1 Oct 2024 · ERS Congress 2024

    ERS 2024: Validation and Accuracy of the Automated AI-powered Continuous Hyfe Cough Monitoring System

    The Hyfe Cough Monitor System accurately monitors coughing in problematic coughers as they go about their usual daily activities. The ability to continually and passively monitor cough has the potential to improve patient care, cough research and drug development.

    Topics: Validation

  8. Peer-reviewed19 Sep 2024 · ERJ Open Research

    Continuous digital cough monitoring during 6-month pulmonary tuberculosis treatment

    An earlier version of Hyfe’s cough monitoring technology was used to monitor cough for 6 months in this study with patients with pulmonary tuberculosis. Community-based continuous cough monitoring for pulmonary tuberculosis is feasible in low-resource settings.

    Topics: TuberculosisTreatment response

  9. Peer-reviewed1 Aug 2024 · Lung

    Longitudinal Cough Frequency Monitoring in Persistent Coughers: Daily Variability and Predictability

    97 persistent coughers with at least 5 coughs/h were monitored for >20h a day for 30 days in real world environments using Hyfe - 2/3rds of them do not cough like metronomes

    Topics: Chronic coughTrial endpoints & variability

  10. Abstract22 May 2024 · ATS 2024

    ATS 2024: Cough-omics: Quantifying the Variability and Predictability of Daily Cough Countsin Persistent Coughers

    Continuous passive cough monitoring demonstrates the heterogeneous and stochastic pattern of persistent cough and that 24 hour counts often inaccurately reflect longer term cough rates.

    Topics: Chronic coughTrial endpoints & variability

  11. Abstract22 May 2024 · ATS 2024

    ATS 2024: Using Continuous Cough Monitoring to Assess Bronchiectasis Therapy

    This is the first report demonstrating the feasibility of continual cough monitoring to assess the clinical impact of bronchiectasis therapy. The average rate of cough decreased significantly in all patients, suggesting that the airway clearance protocol at National Jewish is effective in rapidly reducing coughing.

    Topics: BronchiectasisTreatment response

  12. Abstract22 May 2024 · ATS 2024

    ATS 2024: Using Cough Sounds to Predict Chest Radiography Results

    In this pilot study, we were able to collect coughs in the course of routine patient workflows and demonstrate that AI enabled algorithms are predictive of which individuals are likely to have an abnormal CXR.

    Topics: Screening & diagnosis

  13. Abstract22 May 2024 · ATS 2024

    ATS 2024: Validation of an Acoustic AI Cough Monitoring System

    Over the 477 hours monitored, 4102 cough-seconds were recorded from the 20 subjects; the CoughMonitor detected 3715 of these (overall sensitivity 90.57%) and had 520 false positives (overall false positive rate of 1.09 false positives per hour).

    Topics: Validation

  14. Peer-reviewed27 Feb 2024 · Lung

    Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real‑World Cohort Study

    Hyfe CoughTracker, a smartphone application, was utilized for cough monitoring in this study. This was the first study to characterize patients with refractory / unexplained chronic cough responding to codeine treatment in a real-world patient registry.

    Topics: Chronic coughTreatment response

  15. Pre-print13 Feb 2024 · arXiv

    Leveraging Cough Sounds to Optimize Chest X-ray Usage in Low-resource Settings

    This pilot study suggests that the acoustic pattern of a solicited cough can help to identify which patients are most likely to have abnormal chest radiographs. AI-enabled cough classification may become a routine tool used by front line healthcare personnel.

    Topics: Screening & diagnosis

2023

  1. Peer-reviewed9 Nov 2023 · BMJ Open Respiratory Research

    Performance evaluation of human cough annotators: optimal metrics and sex differences

    Study on reliability of human annotators finds high agreement within as well as between annotators. Using cough seconds reduces discrepancies by 50% vs. counting coughs. Also reveals significant differences in the length and frequency of cough sounds between men and women.

    Topics: ValidationMethods & statistics

  2. Peer-reviewed13 Oct 2023 · Lung

    Feasibility and Utility of a Smartphone Application-Based Longitudinal Cough Monitoring in Chronic Cough Patients in a Real-World Setting

    The substantial day-to-day variability in objective cough frequency highlights the need for continuous monitoring. Grasping the implications of daily cough variability is crucial in both clinical practice and clinical trials.

    Topics: Chronic coughTrial endpoints & variability

  3. Research memo19 Sep 2023 · Hyfe

    Towards a Neural Cough Classifier for Edge Devices

    Category-defining system for real-time, accurate cough detection using neural networks, optimized for integration into various devices with limited computational resources. Significant step in healthcare tech, offering enhanced capabilities for cough monitoring in diverse appllications

    Topics: Validation

  4. Abstract2 Aug 2023 · American Cough Conference 2023

    ACC 2023: Validation of the Hyfe Cough Monitoring System

    Assesses the accuracy and reliability of the Hyfe CoughMonitor, with expected high correlation for both cough and cough-seconds. The AI-powered capabilities provide continuous and non-intrusive monitoring, and have the potential to improve patient care, cough research and support drug development.

    Topics: Validation

  5. Pre-print10 Jul 2023 · arXiv

    Predicting Tuberculosis from Real-World Cough Audio Recordings and Metadata

    Results suggest mobile phone-based applications that integrate clinical symptoms and cough sound analysis could help community health workers and, most importantly, health service programs to improve TB case-finding efforts while reducing costs, which could substantially improve public health.

    Topics: TuberculosisScreening & diagnosis

  6. Peer-reviewed1 Mar 2023 · The International Journal of Tuberculosis and Lung Disease

    Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring

    Continuous cough monitoring in a multi-country cohort of people being evaluated for Tuberculosis showed that people with TB cough a lot more often than those with other respiratory conditions. The distinct cough patterns in TB patients could be used for improved diagnosis and treatment response monitoring.

    Topics: TuberculosisScreening & diagnosisTreatment response

  7. Research memo1 Mar 2023 · Hyfe

    CoughMonitor Pilot Validation: Data Analysis and Presentation

    This paper describes a pilot study aimed at quantifying the accuracy of AI enabled cough monitoring. We have established a rigorous methodology for evaluating and reporting results and claims to its performance, making us confident that the current version of Hyfe Cough Monitoring System will achieve clinically meaning

    Topics: Validation

  8. Peer-reviewed9 Jan 2023 · Journal of Biomedical Informatics

    Digital Cough Monitoring - A Potential Predictive Acoustic Biomarker Of Clinical Outcomes in Hospitalized COVID-19 Patients

    According to this multi-center study results, patients hospitalized with COVID-19 who coughed 3.4 times per hour or less based on digital cough monitoring faced a greater risk for intubation or death.

    Topics: COVID-19 & respiratory infectionsScreening & diagnosis

2022

  1. Abstract30 Oct 2022 · ASTMH Annual Meeting 2022

    ASTMH 2022: Revisiting a neglected symptom: clinical experience using the Hyfe Cough Tracker in malaria patients

    Malaria patients had an almost two-fold probability to experience more than 10 episodes of cough in 30min than patients with other respiratory diseases. These results stress the importance of respiratory symptoms in malaria patients.

    Topics: Other conditionsScreening & diagnosis

  2. Abstract4 Sep 2022 · ERS Congress 2022

    ERS 2022: Continuous cough monitoring with AI. Cases: treatment response, smoking cessation and COVID-19

    This e-poster was presented as an oral presentation at ERS 2022 Congress in Barcelona. Based on our experience and case examples presented - objective cough frequency data has great potential to be a part of remote patient monitoring, smoking cessation and medication adherence, and complement PROs.

    Topics: COVID-19 & respiratory infectionsOther conditionsTreatment response

  3. Peer-reviewed16 Aug 2022 · Lung

    The Statistics of Counting Coughs: Easy as 1, 2, 3?

    Cough is one of the most common reasons that individuals seek health care, and yet it is largely unmeasured in clinical medicine and practice.

    Topics: Chronic coughMethods & statisticsTrial endpoints & variability

  4. Abstract13 Jul 2022 · London International Cough Symposium 2022

    12th LICS: Usability, feasibility, and effectiveness of continuous cough frequency monitoring with Hyfe Cough Tracker in patients with chronic cough

    This study with 65 chronic cough patients monitored for more than a week suggests that continuous cough frequency monitoring with Hyfe Cough Tracker is potentially useful and applicable to real-world clinical practice.

    Topics: Chronic coughTrial endpoints & variability

  5. Pre-print9 Jul 2022 · medRxiv

    Feasibility and analysis considerations of continuous community-based cough monitoring in low- and middle-income settings

    Continuous cough monitoring using a smartphone application is feasible in low- and middle-income country settings, as shown in this study with 568 participants with presumptive Tuberculosis that were monitored for cough frequency dynamics for at least 10 days.

    Topics: TuberculosisScreening & diagnosis

  6. Peer-reviewed6 Jul 2022 · Communications Medicine

    Making cough count in tuberculosis care

    Cough assessment is central to the clinical management of respiratory diseases, including tuberculosis (TB), but strategies to objectively and unobtrusively measure cough are lacking. Validated cough assessment could support public health programs at various stages of the TB care cascade.

    Topics: TuberculosisScreening & diagnosis

  7. Peer-reviewed1 Jul 2022 · F1000Research

    Performance evaluation of the smartphone-based AI cough monitoring app - Hyfe Cough Tracker against solicited respiratory sounds

    Hyfe Cough Tracker app showed a very high correlation between the cough rate measured by Hyfe and that of human annotators (Pearson correlation of 0.968).

    Topics: Validation

  8. Abstract27 Jun 2022 · CHEST 2022

    CHEST 2022: Cough monitoring using artificial intelligence to complement smoke cessation interventions

    We have observed how objective cough frequency dynamics motivate smokers to quit smoking. A case of a 71 year-old female with a history of smoking 20-40 cigarettes/day between ages 18 to 36, and from age 67 to present is described.

    Topics: Other conditionsTreatment response

  9. Peer-reviewed30 May 2022 · ERJ Open Research

    Acoustic surveillance of cough for detecting respiratory disease using artificial intelligence

    This study followed-up 616 participants and collected >62 000 coughs showed that artificial intelligence systems can detect changes in cough frequency that temporarily correlate with the onset of clinical disease at the individual level.

    Topics: COVID-19 & respiratory infectionsSurveillance

  10. Abstract19 May 2022 · ATS Respiratory Innovation Summit 2022

    ATS 2022 Respiratory Innovation Summit: Hyfe Cough Monitoring System: Making Cough Count

    This poster overviews Hyfe's values: insights for patient care, clinical cohort management and a powerful research tool.

  11. Peer-reviewed16 May 2022 · ERJ Open Research

    Longitudinal Passive Cough Monitoring and Its Implications for Detecting...

    Detecting changes in cough rates is complicated by significant stochastic variability. This study monitored cough continuously in a large cohort, allowing for comparison of cough estimates from different observation periods. Intermittent sampling as 24-hour monitoring can often be misleading.

    Topics: Trial endpoints & variabilityMethods & statistics

  12. Peer-reviewed25 Apr 2022 · Asia Pacific Allergy

    Long-COVID severe refractory cough: discussion of a case with 6-week longitudinal cough characterization

    This publication suggests that continuous cough monitoring can be used in remote patient monitoring, with a case of a patient with Long-COVID presented.

    Topics: COVID-19 & respiratory infectionsChronic coughTreatment response

  13. Peer-reviewed22 Apr 2022 · DIGITAL HEALTH

    High-throughput digital cough recording on a university campus

    4302 coughs were recorded from 960 participants over 11 weeks, requiring approximately 30s to check-in a participant and collect their cough. This study shows that acoustic screening at scale is possible, easy and quick to implement.

    Topics: COVID-19 & respiratory infectionsSurveillance

  14. Peer-reviewed23 Mar 2022 · eBioMedicine

    Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?

    This review summarises key technologies in Tuberculosis triage and confirmation. Technologies such as artificial intelligence-based methods are particularly promising, with Hyfe featured as a potential rapidly scalable, and rapid screening tool for cough sound specimens.

    Topics: TuberculosisScreening & diagnosis

2021

  1. Peer-reviewed2 Jul 2021 · BMJ Open

    Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study

    Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain. Real-time tracking of the COVID-19 pandemic and detection of the emergence of novel variants or other respiratory pathogens represent challenges for public health authorities globally..

    Topics: COVID-19 & respiratory infectionsSurveillance

  2. Research memo1 May 2021 · Hyfe

    Cough detection & classification: preliminary validation of Hyfe cough detection & classification

    We use multiple approaches to evaluate the accuracy of Hyfe’s cough detection algorithms and the performance of its apps in various real-world scenarios. In a clinical context, Hyfe has optimized its apps for high performance in quiet indoor settings, such as a bedroom or hospital room, for any user, and for all...

    Topics: Validation

  3. Research memo1 Feb 2021 · Hyfe

    Effects of distance on Hyfe performance

    Hyfe is designed for individual users. High performance means detecting all coughs from a nearby user and no ambient coughs from others in the distance. To achieve this, Hyfe uses various metrics to sort out the soundscape it is analyzing, filtering to loud noise...

    Topics: Validation

  4. Research memo5 Jan 2021 · Hyfe

    AI-powered cough counting: an objective and scalable endpoint

    Cough is a ubiquitous health indicator whose impact is extreme and underappreciated. As an information-rich symptom that is associated with a myriad of diseases, cough is also the ideal clinical endpoint. Yet, cough continues to be assessed mainly through limited subjective methods.

    Topics: Trial endpoints & variability

  5. Research memo3 Jan 2021 · Hyfe

    Risk scores in real-time: the untapped potential of mobile health

    Cough is an information-rich and readily monitored syndrome that will pioneer ’smart risk profiling’ systems, prove their value in alleviating the global burden of respiratory disease, and usher in a new era of proactive mobile health.

    Topics: Surveillance

  6. Research memo2 Jan 2021 · Hyfe

    Hyfe Vision Paper: Acoustic AI as a scalable tool for diagnostics & monitoring

    Hyfe's vision for a healthier world, in which smartphones and acoustic epidemiology identify illness and track health, transforming healthcare systems for good.

    Topics: Screening & diagnosisSurveillance

  7. Research memo1 Jan 2021 · Hyfe

    White Paper: Smart cough monitoring - an innovation milestone for global respiratory health

    Topics: Surveillance